Literature DB >> 22868447

Spred-2 deficiency exacerbates acetaminophen-induced hepatotoxicity in mice.

Hiroshi Wakabayashi1, Toshihiro Ito, Soichiro Fushimi, Yuki Nakashima, Jyunya Itakura, Liu Qiuying, Min Min Win, Sun Cuiming, Cao Chen, Miwa Sato, Megumi Mino, Tetsuya Ogino, Hirofumi Makino, Akihiko Yoshimura, Akihiro Matsukawa.   

Abstract

MAPKs are involved in acetaminophen (APAP)-hepatotoxicity, but the regulatory mechanism remains unknown. Here, we explored the role of Spred-2 that negatively regulates Ras/ERK pathway in APAP-hepatotoxicity. Spred-2 knockout (KO) mice demonstrated exacerbated liver injury, an event that was associated with increased numbers of CD4(+) T, CD8(+) T and NK cells in the liver compared to the control. Levels of CXCL9/CXCL10 that attract and activate these cells were increased in Spred-2 KO-liver. Kupffer cells isolated from Spred-2 KO mice after APAP challenge expressed higher levels of CXCL9/CXCL10 than those from the control. Upon stimulation with APAP or IFNγ, naïve Kupffer cells from Spred-2 KO mice expressed higher levels of CXCL9/CXCL10. NK cell-depletion attenuated APAP-hepatotoxicity with lowered hepatic IFNγ and decreased numbers of not only NK cells but also CD4(+) T and CD8(+) T cells in the liver. These results suggest that Spred-2 negatively regulates APAP-hepatotoxicity under the control of Kupffer cells and NK cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868447     DOI: 10.1016/j.clim.2012.07.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia.

Authors:  Toshihiro Ito; Junya Itakura; Sakuma Takahashi; Miwa Sato; Megumi Mino; Soichiro Fushimi; Masao Yamada; Tuneo Morishima; Steven L Kunkel; Akihiro Matsukawa
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

2.  Altered protein S-glutathionylation identifies a potential mechanism of resistance to acetaminophen-induced hepatotoxicity.

Authors:  David J McGarry; Probir Chakravarty; C Roland Wolf; Colin J Henderson
Journal:  J Pharmacol Exp Ther       Date:  2015-08-26       Impact factor: 4.030

3.  CXC chemokine IP-10: a key actor in liver disease?

Authors:  Lin-Jiao Chen; Juan Lv; Xiao-Yu Wen; Jun-Qi Niu
Journal:  Hepatol Int       Date:  2013-07-16       Impact factor: 6.047

4.  Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.

Authors:  Takahiro Ohkura; Teizo Yoshimura; Masayoshi Fujisawa; Toshiaki Ohara; Rie Marutani; Kaya Usami; Akihiro Matsukawa
Journal:  Front Immunol       Date:  2019-01-22       Impact factor: 7.561

5.  Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4+ and CD8+ T cells.

Authors:  Cuiming Sun; Masayoshi Fujisawa; Toshiaki Ohara; Qiuying Liu; Chen Cao; Xu Yang; Teizo Yoshimura; Steven L Kunkel; Akihiro Matsukawa
Journal:  J Adv Res       Date:  2021-04-20       Impact factor: 10.479

6.  Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.

Authors:  Shinsuke Oda; Masayoshi Fujisawa; Li Chunning; Toshihiro Ito; Takahiro Yamaguchi; Teizo Yoshimura; Akihiro Matsukawa
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

7.  Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy.

Authors:  Suzanne M Abimosleh; Cuong D Tran; Gordon S Howarth
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

8.  Spred2-deficiecy Protects Mice from Polymicrobial Septic Peritonitis by Enhancing Inflammation and Bacterial Clearance.

Authors:  Junya Itakura; Miwa Sato; Toshihiro Ito; Megumi Mino; Soichiro Fushimi; Sakuma Takahashi; Teizo Yoshimura; Akihiro Matsukawa
Journal:  Sci Rep       Date:  2017-10-09       Impact factor: 4.379

9.  Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.

Authors:  Joost Willebrords; Michaël Maes; Isabel Veloso Alves Pereira; Tereza Cristina da Silva; Veronica Mollica Govoni; Valéria Veras Lopes; Sara Crespo Yanguas; Valery I Shestopalov; Marina Sayuri Nogueira; Inar Alves de Castro; Anwar Farhood; Inge Mannaerts; Leo van Grunsven; Jephte Akakpo; Margitta Lebofsky; Hartmut Jaeschke; Bruno Cogliati; Mathieu Vinken
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-12       Impact factor: 5.187

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.